期刊文献+

老年原发性高血压脉压与血栓前状态的临床研究 被引量:5

Study on the relationship between the pulse pressure and prethrombotic stage in elderly essential hypertensive patients
在线阅读 下载PDF
导出
摘要 目的研究老年原发性高血压(Essential hypertension,EH)患者脉压(Pulse pressure,PP)与血栓前状态分子标志物的相关性,探讨其易并发血栓性疾病的机制,为临床早期诊治提供客观依据。方法测量148例老年EH患者的PP,根据PP分为PP1组(PP≤60 mmHg)、PP2组(60 mm<PP≤80 mm Hg)和PP3组(PP>80 mmHg);检测患者血浆血栓前状态(Prethrombotic state,PTS)分子标志物血管性血友病因子(Von Willebrand factor,vW F)、D二聚体(D-dimer)、纤维蛋白原(Fi-brinogen,FIB)的含量。结果 PP与PTS分子标志物水平有较好的相关性;随着PP的升高,PTS分子标志物水平也随之增加,差异有统计学意义(P<0.05)。结论老年EH患者的PP与血浆PTS分子标志物明显相关。PTS与病情进展及血栓性疾病的发生密切相关。 Objective To study the relationship between pulse pressure(PP) and molecular markers of prethrombotic state in old patients with essential hypertension. Methods The PP was measured in 148 cases of elderly patients with essential hypertension. The old patients were divided into three groups:PP1 group (PP≤60 mmHg) ;PP2 group (60 mm〈 PP≤ 80 mmHg) ;PP3 group (PP 〉 80 mmHg). Molecular markers of prethrombotic state ( vWF, D-direct and FIB) were analyzed. Results As the pressure increases, PTS molecular markers levels also increases, the difference was statistically significant (P 〈 0.05 ). Pulse pressure and PTS molecular marker levels have good relativity. Conclusions In elderly patients with essential hypertension pulse pressure and plasma PTS molecu- lar markers have obvious correlatio. PTS maybe closely related to the progress of the disease and the occurrence of thrombotic diseases.
出处 《实用医院临床杂志》 2012年第5期62-64,共3页 Practical Journal of Clinical Medicine
关键词 高血压 脉压 血栓前状态 老年 Hypertension Pulse pressure Prethrombotic state Eldorly
  • 相关文献

参考文献10

  • 1胡大一,王宏宇.高血压病流行的全球趋势及对策[J].中国实用内科杂志,2002,22(4):193-195. 被引量:141
  • 2任军梅,王瑞英.老年高血压患者脉压与靶器官损害[J].心血管病学进展,2005,26(2):141-143. 被引量:7
  • 3中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版)[M].北京:人民卫生出版社,2005.
  • 4Rekhviashvili A, Abasllidze R. The relationship between endothelial dysfunction and 24-hour blood pressue rhythm in patients with arteri- al hypertension[ J]. Georgian Med News,2008,155 : 13-17,.
  • 5Tabak O, Gelisgen R, Uzun H, et al. Hypertension and hemostatic/fi- brinolytic balance disorders [ J ]. Clin Invest Med, 2009,32 ( 6 ) : E285-E292.
  • 6姜文清,曹雁阁,刘成伟.心房颤动患者止凝血分子标志物的检测及意义[J].临床心血管病杂志,2004,20(1):31-32. 被引量:10
  • 7Psbinger I, Ay C. Venous thromboembolism: mechanisms, treatment, and public awareness[ J ]. Arterioscler Thromb Vasc Biol, 2009,29 : 332-336.
  • 8马会利,卢鑫,杨慧娟,张丽娜,邹建宏,赵贵锋,胡桃红,陈纪林,葛均波.纤维蛋白原是冠心病的独立危险因素之一[J].血栓与止血学,2008,14(1):8-11. 被引量:10
  • 9Rizzo M, Corrado E, Coppola G, et al. Markers of inflammation arestrong predictors of subclinical and clinical ath erosclerosis in women with hypertension [ J ]. Coron Artery Dis,2009,20 (1) :15-20.
  • 10Spencer CG, Felmeden DC, Blann AD, et al. Haemorheological, platelet and endothelial indices in relation to global measures of car- diovascular risk in hypertensive patients : a substudy of the AngloScandinavian Cardiac Outcomes Trial [J]. J Int Ern Med,2007,61 (1) :82-90.

二级参考文献26

  • 1付明德.纤维蛋白原与心血管病[J].心血管病学进展,1994,15(4):197-201. 被引量:26
  • 2[1]SMITH G D,HARBORD R,MILTON J,et al.Does elevated plasma fibrinogen increase the risk of coronary heart disease:Evidence from a Meta-analysis of genetic association Studies.Arterioscler[J].Thromb Vasc Biol,2005,25(10):2228-2233.
  • 3[2]BLAKE GJ,SCHMITZ C,LINDPAINTNER K,et al.Mutation in the promotor region of the beta-fibrinogen gene and the risk of future myocardial infarction,stroke and venous thrombosis[J].Eur Heart J,2001,22:2224-2226.
  • 4[3]MILLS J,MANSFIERLD M,GRANT P.Elevated fibrinogen in the healthy male relatives of patients with severe,premature coronary artery disease[J].Eur.Heart J,2002,23,1276.
  • 5[4]RENNER W,CICHOCKI L,FORJANICS A,et al.G-455A polymorphism of the fibrinogen beta gene and deep vein thrombosis[J].Eur J Clin Invest,2002,32(10):721-722.
  • 6[5]LEVENSON J,GIRAL P,RAZAVIAN M,et al.Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors[J].Arterioscler Thromb Vasc Biol,1995,15:1263-1268.
  • 7[6]BECKER RC,CANNON CP,BOVILL EG,et al.Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)[J].Am J Cardiol,1996,78:142-147.
  • 8[7]MICHELA Vi,FRANCESCO Z,MARIA BD,et al.Analysis of gene environment interaction in coronary heart disease:fibrinogen polymorphisms as an example[J].ital Heart J,2002,3:18-23.
  • 9[8]BALAGOPAL P,SWEETEN S,MAURA S.Increased synthesis rate of fibrinogen as a basis for its elevated levels in obese female adolescents[J].Am J Physiol Endocrinol Metab,2002,282,E899-904.
  • 10[9]HUMPHRIES SE,LUONG LA,MONTGOMERY HE,et al.Gene-environment interaction in the determination of levels of plasma fibrinogen[J].Thrombosis and Haemostasis,1999,82:818-825.

共引文献280

同被引文献33

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部